Application of combination of zoledronic acid and organic selenium compound in the preparation of antitumor drugs
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JINAN UNIVERSITY
- Publication Date
- 2021-12-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of tumor treatment, in particular to the combined use of zoledronic acid and an organic selenium compound in the preparation of antitumor drugs. Background technique
[0002] Prostate cancer is one of the common malignant tumors of the male genitourinary system, and the incidence rate is increasing year by year and tends to be younger. Because the onset of prostate cancer is hidden, its symptoms are often ignored. When it is diagnosed, about 65% to 75% have already There is bone metastases. Prostate cancer bone metastasis will cause a series of bone-related diseases, including pathological fractures, spinal cord compression, malignant tumor hypercalcemia, etc. Bone pain is the most common symptom of advanced prostate cancer, which seriously affects the quality of life of patients. Therefore, how to improve the treatment effect while relieving the patient's pain and ensuring the quality of life of the patien...